Using a Personal Glucose Meter and Alkaline Phosphatase for Point-of-Care Quantification of Galactose-1-Phosphate Uridyltransferase in Clinical Galactosemia Diagnosis

Jingjing Zhang, Yu Xiang, Donna E. Novak, George E. Hoganson, Junjie Zhu, Yi Lu

Research output: Contribution to journalArticlepeer-review

Abstract

The personal glucose meter (PGM) was recently shown to be a general meter to detect many targets. Most studies, however, focus on transforming either target binding or enzymatic activity that cleaves an artificial substrate into the production of glucose. More importantly, almost all reports exhibit their methods by using artificial samples, such as buffers or serum samples spiked with the targets. To expand the technology to even broader targets and to validate its potential in authentic, more complex clinical samples, we herein report expansion of the PGM method by using alkaline phosphatase (ALP) that links the enzymatic activity of galactose-1-phosphate uridyltransferase to the production of glucose, which allows point-of-care galactosemia diagnosis in authentic human clinical samples. Given the presence of ALP in numerous enzymatic assays for clinical diagnostics, the methods demonstrated herein advance the field closer to point-of-care detection of a wide range of targets in real clinical samples.

Original languageEnglish (US)
Pages (from-to)2221-2227
Number of pages7
JournalChemistry - An Asian Journal
Volume10
Issue number10
DOIs
StatePublished - Oct 1 2015

Keywords

  • alkaline phosphatase
  • biosensors
  • carbohydrates
  • galactosemia
  • personal glucose meter

ASJC Scopus subject areas

  • Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Using a Personal Glucose Meter and Alkaline Phosphatase for Point-of-Care Quantification of Galactose-1-Phosphate Uridyltransferase in Clinical Galactosemia Diagnosis'. Together they form a unique fingerprint.

Cite this